Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes

Blood

Volumn 91, Issue 7, 1998, Pages 2305-2312

  Chavakis, Triantafyllos ^b   Kanse, Sandip M ^b   Yutzy, Barbara ^b   Lijnen, H Roger ^b   Preissner, Klaus T ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPASE C; UROKINASE; UROKINASE RECEPTOR; VITRONECTIN;

ARTICLE; CELL ACTIVATION; CELL SURFACE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR BINDING; VASCULAR SMOOTH MUSCLE;

EID: 0032055937     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.7.2305.2305_2305_2312     Document Type: Article

References (51)

1. Brunner G, Preissner KT: Pericellular enyzmatic hydrolysis: Implications for the regulation of cell proliferation in the vessel wall and the bone marrow. Blood Coagul Fibrinol 5:625, 1994
2. Bu G, Warshawsky I, Schwartz AL: Cellular receptors for the plasminogen activators. Blood 83:3427, 1994
3. Blasi F: Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasiveness. BioEssays 15:105, 1993
4. Okada S, Grobmyer S, Barnathan E: Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasion. Arterioscl Thromb Vasc Biol 16:1269, 1996
5. Besser D, Verde P, Nagamine Y, Blasi F: Signal transduction and the u-PA/u-PAR system. Fibrinolysis 10:215, 1996
6. Okada SS, Tomaszewski JE, Barnathan ES: Migrating vascular smooth muscle cells polarize cell surface urokinase receptors after injury in vitro. Exp Cell Res 217:180, 1995
7. Behrendt N, Ronne E, Dano K: The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface. Biol Chem Hoppe Seyl 376:269, 1995
8. Gyetko MR, Todd RF III, Wilkinson CC, Sitrin RG: The urokinase receptor is required for human monocyte chemotaxis in vitro. J Clin Invest 93:1380, 1994
9. Resnati M, Guttinger M, Valcamonica S, Sidenius N, Blasi F, Fazioli F: Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J 15:1572, 1996
10. Waltz DA, Sailor LZ, Chapman HA: Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors. J Clin Invest 91:1541, 1993
11. Sitrin RG, Todd RF, Petty HR, Brock TG, Shollenberger SB, Albrecht E, Gyetko MR: The urokinase receptor (CD87) facilitates CD11B/CD18-mediated adhesion of human monocytes. J Clin Invest 97:1942, 1996
12. Sitrin RG, Shollenberger SB, Strieter RM, Gyetko MR: Endogenously produced urokinase amplifies tumor necrosis factor-α secretion by THP-1 mononuclear phagocytes. J Leukoc Biol 59:302, 1996
13. Cao D, Mizukami IF, Garni Wagner BA, Kindzelskii AL, Todd RF, Boxer LA, Petty HR: Human urokinase-type plasminogen activator primes neutrophils for Superoxide anion release. Possible roles of complement receptor type 3 and calcium. J Immunol 154:1817, 1995
14. Rao NK, Shi G-P, Chapman HA: Urokinase receptor is a multifunctional protein: Influence of receptor occupancy on macrophage gene expression. J Clin Invest 96:465, 1995
15. 2-integrins, and scr-kinases within a single receptor complex of human monocytes. J Exp Med 181:1381, 1995
16. Simon DI, Rao NK, Xu H, Wei Y, Majdic O, Ronne E, Kobzik L, Chapman HA: Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells. Blood 88:3185, 1996
17. Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, Doyle MV, Chapman HA: Regulation of integrin function by the urokinase receptor. Science 273:1551, 1996
18. Mizukami IF, Faulkner NE, Gyetko MR, Sitrin RG, Todd RF III: Enzyme-linked immunoabsorbent assay detection of a soluble form of urokinase plasminogen activator receptor in vivo. Blood 86:203, 1995
19. Petty HR, Todd RF: Integrins as promiscuous signal transduction devices. Immunol Today 17:209, 1996
20. Preissner KT, Pötzsch B: Vessel wall-dependent metabolic pathways of the adhesive proteins, von-Willebrand-factor and vitronectin. Histol Histopathol 10:239, 1995
21. Loridon-Rosa B, Vielh P, Cuadrado C, Burtin P: Comparative distribution of fibronectin and vitronectin in human breast and colon carcinomas. Am J Comp Pathol 90:7, 1988
22. Kanse SM, Kost C, Wilhelm OG, Andreasen PA, Preissner KT: The urokinase receptor is a major vitronectin binding protein on endothelial cells. Exp Cell Res 224:344, 1996
23. Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA: Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 269:32380, 1994
24. 158. J Biol Chem 262:5682, 1987
25. 2-terminal amino acid sequence and glycosylation variants. J Biol Chem 265:6453, 1990
26. Behrendt N, Ploug M, Patthy L, Houen G, Blasi F, Dano K: The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator. J Biol Chem 266:7842, 1991
27. Preissner KT, Wassmuth R, Müller-Berghaus G: Physicochemical characterization of human S-protein and its function in the blood coagulation system. Biochem J 231:349, 1985
28. Stockmann A, Hess S, Declerck P, Timpl R, Preissner KT: Multimeric vitronectin. Identification and characterization of conformation-dependent self-association of the adhesive protein. J Biol Chem 268:22874, 1993
29. Kost C. Stüber W, Ehrlich H, Pannekoek H, Preissner KT: Mapping of binding sites for heparin, plasminogen activator inhibitor-1 and plasminogen to vitronectin's heparin binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation. J Biol Chem 267:12098, 1992
30. Völker W, Schön P, Vischer P: Binding and endocytosis of thrombospondin and thrombospondin fragments in endothelial cell cultures analyzed by cuprolinic blue staining, colloidal gold labeling, and silver enhancement techniques. J Histochem Cytochem 29:1385, 1991
31. Murphy-Ullrich JE, Mosher DF: Interactions of thrombospondin with endothelial cells: Receptor-mediated binding and degradation. J Cell Biol 105:1603, 1987
32. Kanse SM, Wijelath E, Kanthou C, Newman P, Kakkar VV: The proliferative responsiveness of human vascular smooth muscle cells to endothelin correlates with endothelin receptor density. Lab Invest 72:376, 1995
33. Fraker PJ, Speck JC: Protein and cell membrane iodination with a sparingly soluble chloramide, 1,3,4,6-tetrachloro-3a,6a-diphenyl-glycoluril. Biochem Biophys Res Commun 80:849, 1978
34. Preissner KT, Anders E, Grulich-Henn J, Müller-Berghaus G: Attachment of cultured human endothelial cells is promoted by specific association with S protein (vitronectin) as well as with the ternary S protein-thrombin-antithrombin III complex. Blood 71:1581, 1988
35. Preissner KT, Grulich-Henn J, Ehrlich HJ, Declerck P, Justus C, Collen D, Pannekoek H, Müller-Berghaus G: Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin. J Biol Chem 265: 18490, 1990
36. Higazi AA-R, Upson RH, Cohen RL, Manuppello J, Bognacki J, Henkin J, McCrae KR, Kounnas MZ, Strickland DK, Preissner KT, Lawler J, Cines DB: Interaction of single-chain urokinase with its receptor induces the appearance and disappearance of binding epitopes within the resultant complex for other cell surface proteins. Blood 88:542, 1996
37. Deng G, Curriden SA, Wang S, Rosenberg S, Loskutoff DJ: Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? J Cell Biol 134:1563, 1996
38. Vassalli JD, Sappino AP, Belin D: The plasminogen activator/ plasmin system. J Clin Invest 88:1067, 1991
39. Mignatti P, Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73:161, 1993
40. Kjoller L, Kanse SM, Kirkegaard T, Rodenburg KW, Ronne E, Goodman SL, Preissner KT, Ossowski L, Andreasen PA: Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation. Exp Cell Res 232:420, 1997
41. Preissner KT, May AE, Wohn KD, Germer M, Kanse SM: Molecular crosstalk between adhesion receptors and proteolytic cascades in vascular remodeling. Thromb Haemost 77:88, 1997
42. Yeh ETH, Rosse WF: Paroxysmal noturnal hemoglobinuria and the glycosylphosphatidylinositol anchor. J Clin Invest 93:2305, 1994
43. Heaney ML, Golde DW: Soluble hormone receptors. Blood 82:1945, 1993
44. Preissner KT, de Boer H, Pannekoek H, de Groot PG: Thrombin regulation by physiological inhibitors: The role of vitronectin. Semin Thromb Hemost 22:165, 1996
45. Herz J, Clouthier DE, Hammer RE: LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation. Cell 71:411, 1992
46. Kounnas MZ, Henkin J, Argraves WS, Strickland DK: Low density lipoprotein receptor-related protein/α2-macroglobulin receptor mediates cellular uptake of pro-urokinase. J Biol Chem 268:21862, 1993
47. 2-macroglobulin/receptor LDL receptor-related protein - Evidence for multiple independent contacts between the ligands and receptor. Ann N Y Acad Sci 737:483, 1994
48. Casaroli Marano RP, Preissner KT, Vilaro S: Fibronectin, laminin, vitronectin and their receptors at newly-formed capillaries in proliferative diabetic retinopathy. Exp Eye Res 60:5, 1995
49. Hammes HP, Weiss A, Hess S, Araki N, Horiuchi S, Brownlee M, Preissner KT: Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina. Lab Invest 75:325, 1996
50. Lupu F, Heim DA, Bachmann F, Hurni M, Kakkar VV, Kruithof EKO: Plasminogen activator expression in human atherosclerotic lesions. Arterioscl Thromb Vasc Biol 15:1444, 1995
51. Carriero MV, Del Vecchio S, Franco P, Potena MI, Chiaradonna F, Botti G, Stoppelli MP, Salvatore M: Vitronectin binding to urokinase receptor in breast cancer. Clin Canc Res 3:1299, 1997